Experience: 10+ years
Specialization: Biotechnology, Oncology, Genetics, Public Health
Dr Nemethova acquired her degree in Molecular biology and genetics and Macromolecular chemistry and has 10+ years of professional background in oncology and cancer genetics. She gained extensive experience working as a specialist in molecular diagnostics at the Center of Molecular Biology and Gene Therapy (CZ) and later became a leader for early stage validation of therapeutic oligonucleotides with exclusive selectivity for leukemia treatment at the Slovak Academy of Sciences. She currently leverages her expertise in the development of safe therapeutic oligonucleotides for oncology patients and implementation of ultrasensitive diagnostic kits for early diagnostics of cancer.
For her remarkable scientific achievements, Dr Nemethova was awarded by the President of the Slovak Republic and Junior Chamber International, by the Slovak Academy of Sciences, and holds the Prize of the Rector of the Slovak Technical University in Bratislava.
Dr Nemethova is the author of 20+ research publications in high-ranked journals and the inventor of 4 subjects of intellectual property.
Dr Nemethova co-founded Selecta Biotech in 2018 with the mission to introduce a new generation of safe therapeutic oligonucleotides for cancer patients.